29,871 results on '"BLOOD coagulation disorders"'
Search Results
2. ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
3. Gene Therapy Study in Severe Hemophilia a Patients with Antibodies Against AAV5 (GENEr8-AAV5+)
4. SWIFT - SWIss Factor XIII Trial in PPH (SWIFT)
5. The Utility of Thromboelastography in Traumatic Brain Injury
6. Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO
7. Frequency, Predictors and Outcome of Sepsis Induced Coagulopathy in Critical Care Unit
8. Pre-hospital Administration of Fibrinogen in Trauma-Induced Coagulopathy (PAF-TIC)
9. Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers (IPNO)
10. Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants
11. Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients
12. Coagulation Disorders Secondary to Two Plasmapheresis Techniques (Double Filtration Plasmapheresis vs. PFS). Descriptive Pilot Study. (APHERCOAG)
13. Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke (PREDICT-EV)
14. Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin
15. The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
16. A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
17. A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
18. Extracorporeal Life Support and Modification of Hemostasis (ELMOH)
19. Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation
20. Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban (ECAN)
21. Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant
22. Quantra Point-of-Care Hemostasis Monitoring (QUANTRA)
23. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)
24. The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin
25. Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy (COMPARE-LAAO)
26. TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study (T-REX HMB)
27. CPP Versus PFC to Correct Coagulation Disorders in Adult Neurosurgical Patients (CLOT-CRANE)
28. Comparison of Rapid-, Kaolin-, and Native-TEG Parameters in Burn Patient Cohorts With Acute Burn-induced Coagulopathy and Abnormal Fibrinolytic Function.
29. Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.
30. Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure
31. Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients. (ROTCLOT)
32. Recombinant vWF Concentrate and ECMO
33. Caudal Block & Hip Fracture Surgery in Anticoagulated Patient
34. Caudal Analgesia & Anticoagulated Patient
35. Quantra® System With the QStat® Cartridge in Trauma
36. Quantra QStat Sample Type Comparison
37. MAC Project, Monitoring of AntiCoagulant Therapies (MAC) (MAC)
38. IV Ketorolac on Platelet Function Post-Cesarean Delivery (KetoPltAgg)
39. Transfusion Surveillance in Anaesthesia (STAR)
40. Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients
41. RAS and Coagulopathy in COVID19
42. Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A (pathfinder™6)
43. The Diagnostic and Prognostic Value of TAT, PIC, tPAI·C and TM in Sepsis-induced Coagulopathy
44. Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD) (PASVAD)
45. Investigation of the Genetics of Hematologic Diseases
46. Establishment of Risk Factors Model of Drug-induced Coagulation Disorder Caused by Cefoperazone Sulbactam Sodium
47. Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B. (paradigm™5)
48. Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B (paradigm™6)
49. The Incidence of Hyperfibrinolysis During Vaginal Delivery and Cesarean Section
50. Quantra vs TEG for Congenital Cardiac Surgery - a Pilot Validation Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.